These data were confirmed by an in vivo study, in which Prmt7+/− mice exposed to cigarette smoke (CSE) showed less monocyte/macrophage infiltration in the lungs and were protected from chronic lung disease [21], suggesting the use of PRMT7 inhibitors as a possible therapeutic strategy to treat COPD. The gene discussed is PRMT7; the disease is chronic lung disease.